Works matching DE "NUCLEOSIDE reverse transcriptase inhibitors"
Results: 565
Nucleoside reverse transcriptase inhibition enhances platelet production and megakaryocyte maturation in patients with COVID‐19.
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 3, p. 846, doi. 10.1111/bjh.20006
- By:
- Publication type:
- Article
Novel Dolutegravir and Lenacapavir Resistance Patterns in Human Immunodeficiency Virus Type 2 Infection: A Case Report.
- Published in:
- Open Forum Infectious Diseases, 2025, v. 12, n. 1, p. 1, doi. 10.1093/ofid/ofae705
- By:
- Publication type:
- Article
Viral Suppression and HIV Drug Resistance Among Patients on Second-Line Antiretroviral Therapy in Selected Health Facility in Ethiopia.
- Published in:
- Viruses (1999-4915), 2025, v. 17, n. 2, p. 206, doi. 10.3390/v17020206
- By:
- Publication type:
- Article
Concise Synthesis of the Anti-HIV Nucleoside EFdA.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2012, v. 76, n. 6, p. 1219, doi. 10.1271/bbb.120134
- By:
- Publication type:
- Article
Prodrugs of γ‐Alkyl‐Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse Transcriptase.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 49, p. 22247, doi. 10.1002/ange.202003073
- By:
- Publication type:
- Article
Determination of the Nucleoside Reverse Transcriptase Inhibitors Lamivudine, Stavudine, and Didanosine in Human Urine by Micellar Electrokinetic Chromatography Using the Ionic Liquid-Based Cationic Surfactant 1-Tetradecyl-3-Methylimidazolium Bromide.
- Published in:
- Analytical Letters, 2021, v. 54, n. 18, p. 2929, doi. 10.1080/00032719.2021.1904970
- By:
- Publication type:
- Article
Revealing the Mutation Patterns of Drug-Resistant Reverse Transcriptase Variants of Human Immunodeficiency Virus through Proteochemometric Modeling.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 9, p. 1302, doi. 10.3390/biom11091302
- By:
- Publication type:
- Article
Nucleoside Analogues Are Potent Inducers of Pol V-mediated Mutagenesis.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 6, p. 843, doi. 10.3390/biom11060843
- By:
- Publication type:
- Article
Clinical Management of Treatment-Experienced, HIV/AIDS Patients in the Combination Antiretroviral Therapy Era.
- Published in:
- PharmacoEconomics, 2010, v. 28, p. 17, doi. 10.2165/11587420-000000000-00000
- By:
- Publication type:
- Article
Characterization of HIV-1 Integrase Gene and Resistance Associated Mutations Prior to Roll out of Integrase Inhibitors by Kenyan National HIV-Treatment Program in Kenya.
- Published in:
- Ethiopian Journal of Health Sciences, 2020, v. 30, n. 1, p. 37, doi. 10.4314/ejhs.v30i1.6
- By:
- Publication type:
- Article
Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals.
- Published in:
- BMC Research Notes, 2012, v. 5, n. 1, p. 180, doi. 10.1186/1756-0500-5-180
- Publication type:
- Article
High failure rates of protease inhibitor-based antiretroviral treatment in rural Tanzania – A prospective cohort study.
- Published in:
- PLoS ONE, 2020, v. 15, n. 1, p. 1, doi. 10.1371/journal.pone.0227600
- By:
- Publication type:
- Article
Genetic diversity and drug resistance of HIV-1 among infected pregnant women newly diagnosed in Luanda, Angola.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0225251
- By:
- Publication type:
- Article
Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0225575
- By:
- Publication type:
- Article
Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0221653
- By:
- Publication type:
- Article
National survey of pre-treatment HIV drug resistance in Cuban patients.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0221879
- By:
- Publication type:
- Article
Understanding acceptance of and adherence to a new formulation of paediatric antiretroviral treatment in the form of pellets (LPV/r)—A realist evaluation.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0220408
- By:
- Publication type:
- Article
Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal Kenya.
- Published in:
- PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0210559
- By:
- Publication type:
- Article
Identification of Fatigue Biomarkers in Treated and Treatment-Naive HIV Patients: Preliminary Results.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Antiviral Medications, Part 2: HIV Antiretroviral Therapy.
- Published in:
- MEDSURG Nursing, 2017, v. 26, n. 5, p. 327
- By:
- Publication type:
- Article
Resource and infrastructure challenges on the RESIST-2 Trial: an implementation study of drug resistance genotype-based algorithmic ART switches in HIV-2-infected adults in Senegal.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Protection of Retinal Function by Nucleoside Reverse Transcriptase Inhibitors Following Retinal Ischemia/Reperfusion Injury.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prevalence and evaluation of risk factors of anti-retroviral therapy failure among human immunodeficiency virus/acquired immune deficiency syndrome patients in North India.
- Published in:
- Transactions of the Royal Society of Tropical Medicine & Hygiene, 2021, v. 115, n. 9, p. 1019, doi. 10.1093/trstmh/trab008
- By:
- Publication type:
- Article
Does a significant reduction in malaria risk make lopinavir/ritonavir-based ART cost-effective for children with HIV in co-endemic, low-resource settings?
- Published in:
- Transactions of the Royal Society of Tropical Medicine & Hygiene, 2014, v. 108, n. 1, p. 49, doi. 10.1093/trstmh/trt108
- By:
- Publication type:
- Article
Antiretroviral therapy options for treatment-naive patients with HIV-1.
- Published in:
- British Journal of Hospital Medicine (17508460), 2015, v. 76, n. 8, p. C122, doi. 10.12968/hmed.2015.76.8.C122
- By:
- Publication type:
- Article
Acquired Human Immunodeficiency Virus Type 1 Drug Resistance in Rhode Island, USA, 2004–2021.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 6, p. 1422, doi. 10.1093/infdis/jiae344
- By:
- Publication type:
- Article
Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 6, p. 1410, doi. 10.1093/infdis/jiae303
- By:
- Publication type:
- Article
Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure.
- Published in:
- Virology Journal, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12985-015-0323-3
- By:
- Publication type:
- Article
Effectiveness of dolutegravir-based regimens compared to raltegravir-, elvitegravir-, bictegravir, and darunavir-based regimens among older adults with HIV in the Veterans Aging Cohort Study (VACS).
- Published in:
- AIDS Research & Therapy, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12981-024-00681-w
- By:
- Publication type:
- Article
HIV drug resistance: analysis of viral genotypes and mutation loci in people living with HIV in Chongqing, China (2016–2023).
- Published in:
- AIDS Research & Therapy, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12981-024-00646-z
- By:
- Publication type:
- Article
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Transplacental Carcinogenesis Induced by Antiretrovirals, Twelve Years Later.
- Published in:
- Environmental & Molecular Mutagenesis, 2019, v. 60, n. 5, p. 443, doi. 10.1002/em.22289
- By:
- Publication type:
- Article
Molecular epidemiology of HIV in a cohort of men having sex with men from Istanbul.
- Published in:
- Medical Microbiology & Immunology, 2013, v. 202, n. 3, p. 251, doi. 10.1007/s00430-012-0285-7
- By:
- Publication type:
- Article
Corrigendum to: Chronic Nucleoside Reverse Transcriptase Inhibitors Disrupt Mitochondrial Homeostasis and Promote Premature Endothelial Senescence.
- Published in:
- Toxicological Sciences, 2021, v. 183, n. 2, p. 415, doi. 10.1093/toxsci/kfab093
- By:
- Publication type:
- Article
Chronic Nucleoside Reverse Transcriptase Inhibitors Disrupt Mitochondrial Homeostasis and Promote Premature Endothelial Senescence.
- Published in:
- Toxicological Sciences, 2019, v. 172, n. 2, p. 445, doi. 10.1093/toxsci/kfz203
- By:
- Publication type:
- Article
Tempol Protects Cardiomyocytes from Nucleoside Reverse Transcriptase Inhibitor-Induced Mitochondrial Toxicity.
- Published in:
- Toxicological Sciences, 2014, v. 139, n. 1, p. 133, doi. 10.1093/toxsci/kfu034
- By:
- Publication type:
- Article
Nucleoside Reverse Transcriptase Inhibitors Induce a Mitophagy-Associated Endothelial Cytotoxicity That Is Reversed by Coenzyme Q10 Cotreatment.
- Published in:
- Toxicological Sciences, 2013, v. 134, n. 2, p. 323, doi. 10.1093/toxsci/kft105
- By:
- Publication type:
- Article
The Molecular Docking of Specific Reverse Transcriptase Inhibitory Ligands onto the Molecular Model of HIV-1 Reverse Transcriptase.
- Published in:
- Trends in Pharmaceutical Sciences, 2024, v. 10, n. 2, p. 91, doi. 10.30476/TIPS.2024.102488.1239
- By:
- Publication type:
- Article
Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 3, p. 549, doi. 10.3390/jcm11030549
- By:
- Publication type:
- Article
Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 9, p. 1928, doi. 10.3390/jcm10091928
- By:
- Publication type:
- Article
Sex Differences in the Expression of Neuroimmune Molecules in the Spinal Cord of a Mouse Model of Antiretroviral-Induced Neuropathic Pain.
- Published in:
- Biomedicines, 2023, v. 11, n. 3, p. 875, doi. 10.3390/biomedicines11030875
- By:
- Publication type:
- Article
Fasting Blood Glucose Profile of Children Living with HIV taking First-Line Antiretroviral Treatment in Abidjan, Cote D'Ivoire: A Cross-Sectional Study.
- Published in:
- Romanian Journal of Diabetes Nutrition & Metabolic Diseases, 2020, v. 27, n. 2, p. 90, doi. 10.46389/rjd-2020-1016
- By:
- Publication type:
- Article
Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men.
- Published in:
- HIV Medicine, 2024, v. 25, n. 9, p. 1058, doi. 10.1111/hiv.13662
- By:
- Publication type:
- Article
Prevalence of people living with multidrug‐resistant HIV and limited treatment options in Spain.
- Published in:
- HIV Medicine, 2024, v. 25, n. 8, p. 946, doi. 10.1111/hiv.13650
- By:
- Publication type:
- Article
Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real‐life experience from a French cohort (2019–2023).
- Published in:
- HIV Medicine, 2024, v. 25, n. 2, p. 299, doi. 10.1111/hiv.13562
- By:
- Publication type:
- Article
Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real‐world setting in Belgium.
- Published in:
- HIV Medicine, 2023, v. 24, n. 8, p. 914, doi. 10.1111/hiv.13493
- By:
- Publication type:
- Article
Bictegravir/emtricitabine/tenofovir alafenamide in patients with genotypic NRTI resistance.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 361, doi. 10.1111/hiv.13376
- By:
- Publication type:
- Article
Effect of HIV and antiretroviral therapy use on body weight changes in a cohort of U.S. veterans living with and without HIV.
- Published in:
- HIV Medicine, 2023, v. 24, n. 2, p. 180, doi. 10.1111/hiv.13366
- By:
- Publication type:
- Article